P3 Health Partners Inc.

P3 Health Partners Inc.

PIII
P3 Health Partners Inc.US flagNASDAQ
10.38
USD
-0.23
- -
34.00MMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
64.33
106.72
360.23
- -
1,261.38
667.29
516.77
446.34
449.4
Basic EPS, GAAP
-32.13
-30.79
-23.04
- -
-324.67
-30.44
-46.79
-45.26
-38.54
Free Cash Flow per Basic Share
-23.87
-21.82
-20.19
- -
-154.15
-41.02
-37.93
-27.91
-26.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
3.36
-29.19
- -
-372.02
-193.55
-173.31
-199.19
-198.39
Tangible Book Value per Share
- -
-6.69
-29.63
- -
-274.51
-122.81
-146.31
-193.53
-185.03
Basic Weighted Avg Shares
1
1
1
- -
1
2
3
3
3
Sales/Revenue/Turnover
88
145
491
- -
1,049
1,266
1,500
1,459
1,472
Operating Margin (%)
-56.69
-27.18
-5.82
- -
-23.44
-13.26
-20.83
-18.53
-15.21
Depreciation Expense
- -
- -
1
- -
87
87
86
84
84
Net Income, GAAP
-44
-42
-31
- -
-270
-58
-136
-148
-126
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-49.95
-28.85
-6.4
- -
-25.74
-4.56
-9.05
-10.14
-8.57
Working Capital
- -
-2
- -
1
-141
-133
-312
-412
-353
LT Debt
- -
19
49
86
106
122
120
240
270
Total Equity
- -
-8
-40
2,064
523
434
150
-140
-133
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-1,831.46
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
39
45
52
LT Borrowings
214
228
260
LT Finance Leases
12
11
11
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
29
11
10

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
136
133
172
Cash, Cash Equivalents & STI
38
25
25
Accounts Receivable, Net
82
92
125
Inventories
- -
- -
- -
Total Current Liabilities
424
545
525
Payables & Accruals
355
414
392
ST Debt
39
45
52
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-1,134.83%
-193.78%
Free Cash Flow
- -
- -
-17.15%
Net Income, GAAP
- -
- -
8.91%
Sales/Revenue/Turnover
- -
- -
-2.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
388
379
362
371
1,500
2025
373
356
345
385
1,459
2026
386
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-7.86
-4.4
-14.37
-18.02
-46.79
2025
-6.28
-6.23
-9.67
-23.02
-45.26
2026
0.37
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Aric Coffman
Full Time Employees
320
Sector
Healthcare
Industry
Medical - Care Facilities
Address
2370 Corporate Circle Henderson NV United States of America 89074
IPO Date
Apr 6, 2021
Website
p3hp.org
Business
P3 Health Partners Inc. (NASDAQ: PIII) is a patient-centered, physician-led population health management company that supports primary care providers with value-based care coordination, administrative services, and technology platforms to improve patient outcomes and reduce costs. Founded in 2015 and headquartered in Henderson, Nevada, the company operates clinics and wellness centers across multiple states including Nevada, Arizona, Oregon, Florida, and California, managing approximately 116,000 at-risk Medicare members through partnerships with over 2,700 affiliated primary care providers (PCPs) in 24 counties. P3 offers capitated revenue arrangements under a fully delegated risk model; care management services including personalized plans, care transitions, chronic disease management, and population health analytics; preventive care programs with education, screenings, and lifestyle support; data integration tools from electronic health records (EHR) and predictive analytics; coordinated care teams addressing social determinants of health; and community outreach initiatives such as health fairs and media appearances. In recent developments, P3 formed a strategic partnership with Innovaccer in June 2024 to deploy the Healthcare AI Platform for personalized interventions and cost management; entered a joint venture with Commonwealth Primary Care in December 2025 to expand into new markets and enhance ACO performance; implemented a 1-for-50 reverse stock split in April 2025; provided preliminary 2025 guidance targeting profitability with $1.4-1.45 billion in revenue and execution of $120-170 million in EBITDA expansion initiatives; and reported third quarter 2025 results showing stable medical cost trends, $345 million in revenue, and positive momentum in its Care Enablement Model.

Company News

APIChatGPT
  • Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

  • P3 Health Partners Announces First Quarter 2026 Results

  • P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

  • P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

  • P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

  • P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

  • P3 Health Partners (NASDAQ:PIII) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey

  • Financial Survey: Mobile-health Network Solutions (NASDAQ:MNDR) vs. P3 Health Partners (NASDAQ:PIII)

  • KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey

  • P3 Health Partners (NASDAQ:PIII) & CVR Medical (OTCMKTS:CRRVF) Head to Head Contrast

  • P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

  • P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

  • P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

  • P3 Health Partners Announces Third Quarter 2025 Results

  • P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

  • P3 Health Partners to Participate in the Jefferies Healthcare Services Conference

  • Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States

  • P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript

  • P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

  • P3 Health Partners Announces Second Quarter 2025 Results